ArticleCureus2026
Serum Magnesium Status and Its Association With Glycemic Control in Adults With Type 2 Diabetes: A Cross-Sectional Study From a Tertiary Care Center.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Magnesium is a crucial component for insulin production and glucose metabolism, and diminished serum magnesium levels are commonly noted in type 2 diabetes mellitus (T2DM). Despite this relevance, magnesium assessment is not frequently conducted in Indian clinical settings. This study sought to measure serum magnesium concentrations in persons with T2DM and examine their correlation with conventional glycemic indicators. Methods A cross-sectional analytical study was performed with 55 patients with T2DM at a tertiary care hospital. Demographic information, fasting blood sugar (FBS), postprandial blood sugar (PPBS), glycated hemoglobin (HbA1c), and serum magnesium concentrations were documented. Magnesium was quantified by spectrophotometry. Group differences were analyzed using Mann-Whitney and Kruskal-Wallis tests, correlations were evaluated with Pearson's coefficients, and linear regression was employed for predictive analysis. Hypomagnesemia was characterized by serum magnesium levels below 1.70 mg/dL. Results The mean serum magnesium level was 1.95 ± 0.33 mg/dL, and 12 patients (21.8%) had hypomagnesemia. Magnesium did not differ by gender (p = 0.214) or age group (p = 0.287). Magnesium levels varied significantly across HbA1c categories (p = 0.0064). Serum magnesium showed significant inverse correlations with HbA1c (r = -0.41), FBS (r = -0.28), and PPBS (r = -0.34). Patients with hypomagnesemia had higher HbA1c (9.72 ± 2.85%) than those with normal magnesium (7.65 ± 1.94%; p = 0.011). Regression analysis showed no predictive ability. Conclusion Hypomagnesemia is common in T2DM and is strongly associated with poorer glycemic control. Routine magnesium assessment may help identify individuals at higher metabolic risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.